Huma
London health platform whose virtual wards and remote monitoring now sit on a broader operating system for regulated care
Quick Overview
| Company | Huma Therapeutics Limited |
|---|---|
| Category | Remote Patient Monitoring Software |
| Headquarters | London, United Kingdom |
| Founded | Not stated |
| EU Presence | Yes - United Kingdom (UK), with a German imprint |
| Data Location | Not stated; the vendor publishes an international data transfer disclosure |
| Open Source | No |
| GDPR Compliant | Yes |
| Self-Hosting | Not stated |
| Main Features | Virtual wards, remote monitoring, condition apps (GDm Health, Huma MG), Huma Workspace, Huma Intelligence, clinical trials, primary care tools, national health system deployments |
| Pricing | Pricing on request |
| Best For | Health systems and governments planning programmes across many pathways |
| Replaces | Biofourmis, large US remote monitoring platforms |
Detailed Review
Huma's home page now calls its offer an operating system for AI in regulated industries covering healthcare, life sciences and governments. Remote monitoring is one use case among several, listed under Virtual Wards and Remote Monitoring.
The website privacy policy names Huma Therapeutics Limited as controller and refers to the ICO, and the legal menu includes a German imprint.
Virtual Wards Page
The remote monitoring page cites more than 450 deployments and states figures such as a 30 percent drop in readmissions and 40 percent less time spent reviewing patients. These are the vendor's own numbers and should be validated in a pilot.
Condition-Specific Apps
Alongside the generic platform it sells GDm Health for diabetes in pregnancy and Huma MG for myasthenia gravis, plus AI-first primary care and cardiovascular screening products.
A Wide Legal Footprint
The legal pages include a quality and regulatory section, an international data transfer disclosure, a mobile app privacy policy and a modern slavery statement. Regional offices span UK and EU, US, Germany, Middle East, APAC and South Africa.
Limitations to Consider
Huma is now a large platform vendor, so remote monitoring is only part of what you would contract for. It has a US office, so check which Huma entity signs your contract. No prices or hosting region are published, and efficacy figures are self-reported. A narrower product such as Medixine is simpler to evaluate.
Who Should Use Huma
National health systems, large provider groups and life-science sponsors that want one platform for several programmes.
Pros and Cons
Pros
- 450+ deployments claimed
- Condition apps already built
- Regulatory and transfer disclosures published
- Presence in UK, EU and Germany
- Covers trials and care delivery
Cons
- Focus has moved to a general operating system
- Efficacy figures are self-reported
- No public pricing
- Contracting entity varies by region
Alternatives to Huma
Other European remote patient monitoring software worth comparing before you decide:
Healthentia
Belgium · Class IIa software for monitoring, coaching and trial data
Medixine
Finland · Configurable monitoring suite with a Bluetooth hub app
Cuviva
Sweden · White-label platform with Swedish storage options
Luscii
Netherlands · Home monitoring programmes for 150+ conditions
See all European remote patient monitoring software or compare them directly against Biofourmis on our alternatives page.
Frequently Asked Questions
Yes, a Virtual Wards and Remote Monitoring solution page remains, but the company now presents itself as an operating system for regulated industries.
Huma Therapeutics Limited is named as controller in the website privacy policy.
GDm Health for diabetes in pregnancy and Huma MG for myasthenia gravis, among others on the product menu.